Shortcut menu
Go to content
Go to footer

Korean

Dong-A ST

  • Dong-A ST

    Dong-A ST - Dong-A ST is leaping forward towards becoming a global pharmaceutical company.

    • Overview
    • CEO’s Message
    • Vision and Values
    • History
    • CI
    • Location

    Dong-A ST menu close

  • Business Areas

    Business Areas- We vow to endeavor to promote human health.

    • Dong-A ST Product
      • Ethical Products
      • Product News
    • Medical Device Business
    • Diagnosis Business
    • Overseas Business
    • License-in
    • License-out
    • Archive

    Business Areas menu close

  • Research and Development

    Research and Development - Our Research Division focuses on the development of global new drugs.

    • Research Division
    • Research Activity
    • Research Achievements
      • Our New Drugs
      • Major Achievements
    • Development stage

    Research and Development menu close

  • CSR

    CSR - We vow to fulfill our corporate social responsibility of creating a bright, warm society.

    • Long March through the National Land
    • Youth Environmental Campaign  Life Love School
    • Golf
    • Other sponsorship programs

    CSR menu colose

  • Investors

    Investment Information - We vow to do our best to reward our shareholders for their strong support.

    • Govornance
      • Shareholderes Meeting
      • Board of Directors
      • Board Committees
      • Audit organization
      • Corporate group
      • Corporate Governance Report
    • Financial Results
    • Stock Information
      • Current price
      • Hourly share price
      • Daily share price
      • Index information
      • Foreigner information
    • Investor Relations
      • Public Notice
      • Presentations
      • Annual Reports
      • IR Inquiry

    Investment Information menu close

  • Newsroom

    Newsroom - Here are the latest news about us, and out latest moves.

    • Newsroom

    Newsroom menu close

  • Contact Us

    Contact Us - Dong-A ST puts its customers first.

    • 1:1 Online Inquiry

    Contact Us menu close

DONG-A ST - Our Research Division focuses on the development of global new drugs.

R&D

  • Research Division
  • Research Activity
  • Research Achievements
    • Our New Drugs
    • Major Achievements
  • Clinical Issues

HOME>Research and Development>Research Achievements>Our New Drugs

Our New Drugs

Overview of Dong-A ST’s new drugs for the promotion of human health
  • Stillen
    Go to product information

    Unveiled domestically in December 2002, Stillen® is
    a natural-material-derived drug using mugwort ingredients, which have been used as a therapy material to treat abdominal tenderness, bloody diarrhea, and gynecological disease.

    Stillen®, which protects the mucous membranes, is highly effective in treating chronic and acute gastritis as well as gastric ulcer, infective enteric disease, and pancriatitis. In 2009, Stillen® posted about KRW85.4 billion sales domestically, making it a successful, highly marketable natural-material-derived drug.

  • Zydena
    Go to product information

    Unveiled in December 2005, Zydena® is the country’s first and the world’s fourth erectile dysfunction drug.

    Zydena® has been clinically proven in the domestic clinical studies and U.S. clinical phase 2 studied to offer high efficacy, few side effects, and appropriate duration time. Four years after its unveiling in 2009, Zydena® posted KRW16.3 billion sales at home, thus squarely rivaling the new drugs of multinational pharmaceutical companies

    In November 2009, we signed contracts to export Zydena® to 32 countries around the world, and its cumulative export contract worth amounted to about USD300 million, the largest for a domestic new drug.

    Zydena was released in several countries including Russia, Turkey, Malaysia, India, and Azerbaijan, followed by Brazil in 2015. Moreover, the NDA for Zydena was submitted to the US FDA in early 2015 and the US FDA approval is expected in early 2016

    For Zydena®, we are researching on expanding its indications for benign prostatic hyperplasia, pulmonary arterial hypertension, etc. We expect to expand the drug’s indications.

  • Motilitone
    Go to product information

    Unveiled domestically in December 2011, Motilitone is a natural-material-derived functional-dyspepsia drug manufactured using extracts of morning glory seeds and corydaline tubers.

    Functional dyspepsia is a disease in which, without particular lesions, indigestion such as premature satiety and abdominal distension continues for more than three months. As such, while the existing digestive medicines temporarily prevent functional disorder of the stomach, Motilitone has the combined advantage of improving both the funtion and motility of CTI. Also, Motilitone has been proven not to produce side effects but to have improved the bowel movement and to have drastically decreased the hypersensitivity reaction of the intestines.

PRIVACY POLICY

  1. Introduction

    This Privacy Policy describes the personally identifiable information that Dong-A ST ("the Company") collects through our Web site located at en.donga-st.com and how we use that information. If you have any questions or comments about this Privacy Policy or our practices regarding your personally identifiable information, please contact us via email or by phone.

  2. Collection of Personal Information

    You can browse our Web site without providing us with any personal information. However, the Company collects your personal information within the scope of its business activities for clearly defined purposes.

  3. Disclosure of Personal Information

    The Company will not disclose, rent, sell or otherwise transfer your personal information without your consent, except as otherwise set out in this Privacy Policy. The Company uses personal information within the limits necessary for the achievement of its objectives.

    The Company may share information provided by our visitors to en.donga-st.com with service providers we have retained to perform services on our behalf. These service providers are contractually restricted from using or disclosing the information except as necessary to perform services on our behalf or to comply with legal requirements. In addition, we may disclose information about you (i) if we are required to do so by law or legal process, (ii) to law enforcement authorities or other government officials, or (iii) when we believe disclosure is necessary or appropriate to prevent physical harm or financial loss or in connection with an investigation of suspected or actual illegal activity.

  4. Changes to this Privacy Policy

    The Company will review this policy in accordance with circumstances and revise it as needed. The revised Privacy Policy will be posted on this Web site. We will treat your personal information in accordance with the Privacy Policy in place at the time of collection of such information, or as you otherwise consent.

팝업 닫기

PRIVACY POLICY

This website is operated by Dong-A ST. All inquiries may be directed to:

Dong-A ST
64 Cheonhodaero, Dongdaemun-gu,
Seoul, Korea

Your use of this website is governed by these terms of use. Please take a few minutes to review these terms when using the Web site.

  1. Copyright Notice

    All of the content you see on this Web site, including, for example, all of images, illustrations, graphics, audio clips, video clips, and text, are subject to trademark, service mark, trade dress, copyright and/or other intellectual property rights or licenses held by Dong-A ST, one of its affiliates or by third parties who have licensed their materials to Dong-A ST. They may therefore not be used without the prior written consent of Dong-A ST for purposes other than to identify and present Dong-A ST’s products and service. The entire content of this Web site is protected under the copyright law of the relevant countries and international treaty. You may download, print and store selected portions of the content, provided you (1) only use these for your own personal, non-commercial use, (2) do not copy or post the content on any network computer or broadcast the content in any media, and (3) do not modify or alter the content in any way, or delete or change any copyright or trademark notice. Any use beyond the provisions outlined above is strictly prohibited

  2. Disclaimer

    While the information on this Web site is given in good faith based upon the latest available to Dong-A ST, no warranty or representation is given concerning such information, which must not be taken as establishing any contractual or other commitment binding upon Dong-A ST or any of its subsidiaries or associated companies.

  3. Changes

    Dong-A ST reserves the right, at its sole discretion, to change, modify, add or remove any portion of this Agreement in whole or in part, at any time. Changes in this Agreement will be effective when notice of such change is posted. Your continued use of the Site after any changes to this Agreement are posted will be considered acceptance of those changes. Dong-A ST may terminate, change, suspend or discontinue any aspect of this Web site, including the availability of any features of the Site, at any time. Dong-A ST may also impose limits on certain features and services or restrict your access to parts or the entire Site without notice or liability.

  4. Linked Sites

    As a convenience to you, we may provide, on this site, links to Web sites operated by other entities. We do not control any of those linked Web sites, we may not have reviewed them, and we make no representations or warranties and assume no responsibility for anything that may happen through your use of any linked Web site. You should read carefully the terms of use of any other Web site that you may use.

팝업 닫기